Inhaled Antibiotic Therapy for Ventilator-Associated Tracheobronchitis and Ventilator-Associated Pneumonia: an Update
- نوع فایل : کتاب
- زبان : انگلیسی
- مؤلف : Tareq Abu-Salah · Rajiv Dhand
- چاپ و سال / کشور: 2011
Description
Ventilator-associated pneumonia (VAP) remains a leading cause of morbidity and mortality in mechanically-ventilated patients in the Intensive Care Unit (ICU). Ventilator-associated tracheobronchitis (VAT) was previously believed to be an intermediate stage between colonization of the lower respiratory tract and VAP. More recent data, however, suggest that VAT may be a separate entity that increases morbidity and mortality, independently of the occurrence of VAP. Some, but not all, patients with VAT progress to develop VAP. Although inhaled antibiotics alone could be effective for the treatment of VAP, the current consensus of opinion favors their role as adjuncts to systemic antimicrobial therapy for VAP. Inhaled antibiotics are increasingly employed for salvage therapy in patients with VAP due to multi-drug resistant Gram-negative bacteria. In contrast to VAP, VAT could be effectively treated with inhaled antibiotic therapy alone or in combination with systemic antimicrobials
Adv Ther (2011) DOI 10.1007/s12325-011-0051-z Received: February 14, 2011 / Published online: August 8, 2011
